Scatec Solar OL (SCATC)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 76.85 |
|---|---|
| 52-week range | 76.05 – 137.60 |
| Return, 1 month / 3 months | −23.5% / −20.7% |
| Return, 1 year / 3 years | −27.6% / +30.6% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 40.7% |
| Worst drawdown (1 year) | -43.4% |
| Average daily value traded | 54.84M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Scatec is a renewable energy company based in Norway that develops, builds, owns and operates solar power plants, and also works on hydropower and wind projects. It supplies electricity through long-term agreements with utilities and other buyers, and provides services to keep power plants running. The company carries out projects in several countries, often in emerging markets, and its business spans the planning, construction and operation of generating assets.
On this site Scatec Solar OL appears as a stock on the Oslo Stock Exchange (Norway), code SCATC, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Scatec Solar OL (SCATC) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 76.85 on 22 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 214 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 27.6% and over the last three months it fell 20.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.2% | ||
| From 52-week high | -43.4% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.7% | ||
| 6-month return | -34.8% | ||
| 12-month return, skipping the last month | -5.3% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.4% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 54.84M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −23.5% |
|---|---|
| 1 month | −23.5% |
| 3 months | −20.7% |
| 6 months | −34.8% |
| 1 year | −27.6% |
| 3 years | +30.6% |
| 5 years | −51.7% |
Signals
| 50-day / 200-day average | 99.14 / 107.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Apr 2023 | NOK 1.9400 |
| 29 Apr 2022 | NOK 2.5400 |
| 21 Apr 2021 | NOK 1.0900 |
| 22 Jul 2020 | NOK 0.9500 |
| 29 Apr 2020 | NOK 1.0500 |
| 2 May 2019 | NOK 0.9500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.